Man Group PLC Intra Cellular Therapies, Inc. Transaction History

Man Group PLC

$35.6 Billion
Q4 2024

A detailed history of Man Group PLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Man Group PLC holds 48,597 shares of ITCI stock, worth $6.38 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

48,597

Previous 27,499 76.72%

Holding current value

$6.38 Million

Previous $2.01 Million 101.89%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$71.19 - $91.57 $1.5 Million - $1.93 Million	21,098 Added 76.72%	48,597 $4.06 Million
Q3 2024 Nov 14, 2024	SELL	$67.99 - $80.84 $2.28 Million - $2.71 Million	-33,502 Reduced 54.92%	27,499 $2.01 Million
Q2 2024 Aug 14, 2024	BUY	$64.76 - $79.84 $3.55 Million - $4.38 Million	54,871 Added 895.12%	61,001 $4.18 Million
Q1 2024 May 15, 2024	BUY	$64.37 - $75.65 $194,461 - $228,538	3,021 Added 97.17%	6,130 $424,000
Q4 2023 Feb 14, 2024	SELL	$46.37 - $73.65 $53,418 - $84,844	-1,152 Reduced 27.04%	3,109 $222,000
Q3 2023 Nov 14, 2023	SELL	$52.09 - $64.1 $11.7 Million - $14.4 Million	-225,275 Reduced 98.14%	4,261 $221,000
Q2 2023 Aug 14, 2023	BUY	$54.67 - $66.44 $12.5 Million - $15.3 Million	229,536 New	229,536 $14.5 Million
Q2 2021 Aug 16, 2021	SELL	$29.3 - $44.5 $298,244 - $452,965	-10,179 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$30.8 - $39.51 $313,513 - $402,172	10,179 New	10,179 $345,000
Q2 2020 Aug 14, 2020	SELL	$14.35 - $26.64 $373,100 - $692,640	-26,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$12.31 - $33.12 $320,060 - $861,119	26,000 New	26,000 $400,000
Q3 2019 Nov 14, 2019	SELL	$7.47 - $14.03 $1.47 Million - $2.76 Million	-196,803 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$10.65 - $14.29 $492,030 - $660,198	-46,200 Reduced 19.01%	196,803 $2.56 Million
Q1 2019 May 15, 2019	BUY	$10.9 - $14.09 $470,880 - $608,688	43,200 Added 21.62%	243,003 $2.96 Million
Q4 2018 Feb 14, 2019	SELL	$10.36 - $20.96 $1.06 Million - $2.15 Million	-102,545 Reduced 33.92%	199,803 $2.28 Million
Q3 2018 Nov 14, 2018	SELL	$17.77 - $22.9 $474,459 - $611,430	-26,700 Reduced 8.11%	302,348 $6.56 Million
Q2 2018 Aug 14, 2018	BUY	$17.33 - $23.4 $1.95 Million - $2.63 Million	112,289 Added 51.8%	329,048 $5.81 Million
Q1 2018 May 15, 2018	BUY	$15.16 - $25.49 $3.29 Million - $5.53 Million	216,759 New	216,759 $4.56 Million

Others Institutions Holding ITCI

# of Institutions

419

Shares Held

88.8M

Call Options Held

284K

Put Options Held

105K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12.4B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account